{"doi":"10.1016/j.annonc.2020.04.375","title":"P-293 Overall survival according to mutation frequency of BRAF, NRAS genes, and MSI status in patients with wild-type KRAS metastatic colorectal cancer treated with cetuximab","abstract":null,"journal":"Annals of Oncology","year":2020,"id":600224,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1538648,"name":"R. Reis","orcid":null,"position":1,"is_corresponding":false},{"id":1538651,"name":"L. Barroti","orcid":null,"position":2,"is_corresponding":false},{"id":1538652,"name":"J. Datorre","orcid":null,"position":3,"is_corresponding":false},{"id":1538654,"name":"A. Pereira","orcid":null,"position":4,"is_corresponding":false},{"id":1538656,"name":"A. Carvalho","orcid":null,"position":5,"is_corresponding":false},{"id":1538658,"name":"G. Berardinelli","orcid":null,"position":6,"is_corresponding":false},{"id":1538659,"name":"R. Araujo","orcid":null,"position":7,"is_corresponding":false},{"id":1538645,"name":"F. Santos","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"P-293 Overall survival according to mutation frequency of BRAF, NRAS genes, and MSI status in patients with wild-type KRAS metastatic colorectal cancer treated with cetuximab","abstract":null,"is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23304386","pmcid":null,"openalex_id":"https://openalex.org/W3040911471","authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0923753420396745?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0923753420396745?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.annonc.2020.04.375","host_type":"journal"}],"fields_of_study":["Colorectal Cancer Treatments and Studies","Genetic factors in colorectal cancer","Cancer Genomics and Diagnostics"],"mesh_terms":[],"keywords":["Medicine","KRAS","Neuroblastoma RAS viral oncogene homolog","Cetuximab","Colorectal cancer","Oncology","Internal medicine","Microsatellite instability","Population","Cancer","Gene","Allele"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T12:31:40.128178Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}